Updated stroke treatment recommendations from the American Heart Association/American Stroke Association include using a stent retrieval device to remove blood clots from large arteries in select patients. Clot-busting medication - tPA - continues to be the gold standard for treating clot-caused stroke. Clot busters and/or clot-removal procedures must be administered within a few hours of stroke symptoms, so call 9-1-1 and seek immediate help if they occur.
The first patients are being enrolled at Miami Cardiac & Vascular Institute at Baptist Hospital in a major national study comparing intensive medical management to carotid endarterectomy, a common operation to prevent stroke, and to carotid artery stenting. The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis study (CREST-2) is supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Building on ILUMIEN I and ILUMIEN II, ILUMIEN III will compare St. Jude Medical’s OCT imaging to intravascular ultrasound and angiography to further shape the standard of care for cardiovascular patients.
Today, the American Heart Association/American Stroke Association (AHA/ASA) published new stroke treatment guidelines that recommend the use of stent retriever technology - such as Medtronic plcs (NYSE: MDT) SolitaireTM stent retriever device - in conjunction with the current standard of care, IV-tPA, as a first-line treatment for eligible patients.
According to a recent report by iData Research, Holmium lasers and ureteral stents are rapidly growing in market value, bringing with them cost-saving advantages that benefit urologists and the stone management market as a whole.
Staying active, never smoking and controlling diabetes and cholesterol can prevent hardening of the arteries, but effective treatment of atherosclerosis could come down to harnessing an enzyme already built in to the blood vessels.
A Norwegian study has indicated that the use of newer biological disease modifying anti-rheumatic drugs (DMARDs) can help reduce reduce cardiovascular disease (CVD) risk factors in patients with rheumatoid arthritis.
A new UK study has provided evidence that coronary heart disease and osteoporosis may share similar underlying causes.
Americas beverage companies are committed to being part of real solutions to public health challenges. This study does not show that consuming sugar-sweetened beverages causes chronic diseases and the authors themselves acknowledge that they are at best estimating effects of sugar-sweetened beverage consumption.
First Carotid Stent Indicated for Transcarotid Use and Optimized for Novel TransCarotid Artery Revascularization (TCAR) Procedure
Silk Road Medical has appointed Andrew Davis to the position of executive vice president of global pales. In this new role, Davis will assemble a sales organisation and lead the company’s commercialisation efforts for the transcarotid artery revascularisation (TCAR) procedure with the Enroute transcarotid neuroprotection system and the Enroute transcarotid stent system.
Philips has announced the launch of Ultrasound on Demand in the UK, an on-demand ultrasound solution which will go live on 1 June 2015.
The positive 30-day results from 120 patients out of a planned 240 patient cohort at high risk for endarterectomy, who underwent carotid artery stenting using the Wirion embolic protection device (Allium Medical), were published in EuroIntervention and presented at EuroPCR 2015 (19–22 May, Paris, France).
Royal Philips and Academic Medical Center (AMC) in Amsterdam, the Netherlands, have announced their collaboration in a European multicentre clinical study to investigate a new diagnostic technique targeting immediate assessment of the results of a minimally-invasive treatment for diabetic foot and critical limb ischaemia.
Penumbra has announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the US Food and Drug Administration for the revascularisation of large vessel occlusions in patients with acute ischaemic stroke.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos